Related Experiment Video

Updated: May 31, 2026

Assessment of Child Anthropometry in a Large Epidemiologic Study
09:36

Assessment of Child Anthropometry in a Large Epidemiologic Study

Published on: February 2, 2017

Correlation between peak flow and body mass index in obese and non-obese children in Kocaeli, Turkey

Zuhal Gundogdu1, Nihal Eryilmaz

  • 1Kocaeli Metropolitan Municipality Hospital, 41100, Kocaeli, Turkey. z.gundo@gmail.com

Primary Care Respiratory Journal : Journal of the General Practice Airways Group
|July 12, 2011
PubMed

Insights

Obese children have lower peak expiratory flow (PEF) than non-obese children. This finding highlights obesity as a risk factor for reduced lung function in children, emphasizing prevention.

Area of Science:

  • Pediatric Health
  • Respiratory Medicine
  • Obesity Research

Background:

  • Childhood obesity is a growing public health concern.
  • Obesity may impact various physiological functions, including respiratory capacity.

Purpose of the Study:

  • To examine the association between Body Mass Index (BMI) and Peak Expiratory Flow (PEF) in children aged 6-14.
  • To determine if obesity affects lung function in pediatric populations.

Main Methods:

  • Cross-sectional study involving 1,439 children during public health screenings.
  • Children categorized as non-obese or obese based on age- and sex-specific BMI percentiles (>95th percentile).
  • Comparison of PEF and BMI across different age-sex-BMI percentile groups.

Main Results:

  • Obese children exhibited significantly lower PEF values compared to non-obese children.
  • Significant differences in PEF were observed between genders.
  • Higher BMI was associated with reduced PEF.

Conclusions:

  • Elevated BMI in children is linked to diminished lung function (lower PEF).
  • Obesity represents a significant risk factor for reduced airflow and respiratory health in children.
  • Preventing childhood obesity is crucial for mitigating future respiratory issues.
Abstract

More Related Videos

Multidisciplinary Approach to Obesity Management: A Case Report05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Related Concept Videos

Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Pulmonary Function Tests01:25

Pulmonary Function Tests

Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History